ASCEND Phase 2 Clinical Trial for Dextromethorphan-Bupropion Produces Positive Results

May 27, 2022 06:10pm

Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.

News Roundup: May 23 to May 27
Artery Stiffness a Better Predictor of T2D Than Blood Pressure
Diabetes Identified as a Top Risk Factor for Dementia
College Students and Misuse of Substances